Suppr超能文献

活体亲属供肾移植术后晚期的肾功能及肾小球滤过选择性

Renal function and glomerular permselectivity late after living related donor transplantation.

作者信息

Borchhardt K A, Yilmaz N, Haas M, Mayer G

机构信息

Department of Internal Medicine III, Division of Nephrology, University of Vienna, Austria.

出版信息

Transplantation. 1996 Jul 15;62(1):47-51. doi: 10.1097/00007890-199607150-00010.

Abstract

Living related kidney transplantation is the preferable procedure for renal replacement therapy. The aim of the current study was to determine systemic hemodynamic and intrarenal adaptions in donors and recipients late after living related kidney transplantation. Furthermore, glomerular permselectivity was assessed in these subjects. We studied mean blood pressure (MAP), glomerular filtration rate (GFR), renal plasma flow (RPF), microalbuminuria (MIA), 24-hr urinary protein excretion, and glomerular permselectivity (fractional clearance of neutral dextrans [thetaD] as a marker for size selectivity and fractional clearance of dextran sulfate [thetaDS] to assess charge selectivity) in 22 donors and 22 recipients. MAP was normal in the donor group (102 +/- 4 mmHg), but five patients had blood pressure above 140/90 mmHg. This 18%, however, is lower than the prevalence of hypertension in the age-adjusted general population in Austria. The recipients also had normal MAP at the time of study (99 +/- 3); however, 13 needed antihypertensive therapy. GFR and RPF were lower in recipients than in donors (53 +/- 8 vs. 72 +/- 11 and 314 +/- 74 vs. 412 +/- 86 ml/min respectively). In the donor group, GFR was 137 +/- 45% of the expected age-adjusted mean value/kidney due to hyperfiltration. Proteinuria and MIA were higher in the recipients than in the donors (0.39 +/- 0.22 vs. 0.07 +/- 0.04 g/day, 137 +/- 136 vs. 26 +/- 15 mg/day). Nonetheless, five donors had an elevated MIA. A higher need for antihypertensive medication could be observed in recipients with previous rejection episodes, as well as a significantly higher urinary protein excretion and MIA (0.7 +/- 0.42 vs. 0.24 +/- 0.14 g/day, 336 +/- 380 vs. 48 +/- 32 mg/day). ThetaDS was significantly higher in the recipients, whereas thetaDS of the donors was identical to the value obtained from 18 healthy controls (0.7 +/- 0.08 vs. 0.6 +/- 0.06). OD was similar in all groups studied. In conclusion, 76 months after uninephrectomy for renal donation, mild changes in glomerular permselectivity occurred in a subset of donors without affecting renal excretory function. In recipients, proteinuria was due to a defect in glomerular charge selectivity.

摘要

亲属活体肾移植是肾脏替代治疗的首选方法。本研究的目的是确定亲属活体肾移植术后晚期供体和受体的全身血流动力学及肾内适应性变化。此外,还评估了这些受试者的肾小球滤过选择性。我们研究了22名供体和22名受体的平均血压(MAP)、肾小球滤过率(GFR)、肾血浆流量(RPF)、微量白蛋白尿(MIA)、24小时尿蛋白排泄量以及肾小球滤过选择性(以中性葡聚糖的分数清除率[θD]作为大小选择性的标志物,硫酸葡聚糖的分数清除率[θDS]用于评估电荷选择性)。供体组的MAP正常(102±4 mmHg),但有5例患者血压高于140/90 mmHg。然而,这一比例为18%,低于奥地利年龄调整后的普通人群中的高血压患病率。研究时受体的MAP也正常(99±3);然而,有13人需要抗高血压治疗。受体的GFR和RPF低于供体(分别为53±8 vs. 72±11和314±74 vs. 412±86 ml/min)。在供体组中,由于超滤,GFR为预期年龄调整后平均值/肾脏的137±45%。受体的蛋白尿和MIA高于供体(0.39±0.22 vs. 0.07±0.04 g/天,137±136 vs. 26±15 mg/天)。尽管如此,有5名供体的MIA升高。既往有排斥反应的受体对抗高血压药物的需求更高,尿蛋白排泄量和MIA也显著更高(0.7±0.42 vs. 0.24±0.14 g/天,336±380 vs. 48±32 mg/天)。受体的θDS显著更高,而供体的θDS与18名健康对照者的值相同(0.7±0.08 vs. 0.6±0.06)。所有研究组的θD相似。总之,肾移植供体单侧肾切除76个月后,一部分供体的肾小球滤过选择性发生了轻微变化,但未影响肾脏排泄功能。在受体中,蛋白尿是由于肾小球电荷选择性缺陷所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验